Much of the excitement, for both type 1 and type 2 diabetes, is about disease modification and claims of drugs being disease modifying. But what does disease modifying mean? Other drugs require ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

This week is a big one for Apple fans ... Here’s what’s on the list: 24-inch iMac: Set to come with the entry-level M4 chip, providing significant performance improvements for general use ...

Bleeding Cool Bestseller List gives the best-selling reported comic of the week the 100.0 number, and you can see how each title performed as a percentage of that sale. These numbers are based on ...

The diabetes drug semaglutide ... them a 50% chance of getting the drug though. The study was conducted in four countries: Canada, Germany, Spain and the Netherlands. Half of the 101 participants ...

Researchers have discovered that semaglutide, a diabetes and weight-loss medication sold under the brand names Wegovy and Ozempic, might significantly reduce the risk of Alzheimer’s in type 2 diabetes ...

as he’s been elevated from the practice squad for this week’s game; both Bernard and Samuel were ruled out on Friday. The rest of the inactives list is unsurprising, as Edwards, Ulofoshio ...

Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia ... and the first to offer a once-weekly regime. Hympavzi has more potential for patients suffering ...

This is the first time that it has been shown that this diabetes drug, now best known as a ... Half of the 101 participants received 24-week injections of semaglutide, while the other half ...